Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Income from Continuing Operations: 2009-2011

Historic Income from Continuing Operations for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$33.8 million.

  • Lexicon Pharmaceuticals' Income from Continuing Operations fell 47.16% to -$33.8 million in Q4 2011 from the same period last year, while for Dec 2011 it was -$115.1 million, marking a year-over-year decrease of 16.06%. This contributed to the annual value of -$116.2 million for FY2011, which is 14.19% down from last year.
  • Lexicon Pharmaceuticals' Income from Continuing Operations amounted to -$33.8 million in Q4 2011, which was down 29.66% from -$26.1 million recorded in Q3 2011.
  • Lexicon Pharmaceuticals' 5-year Income from Continuing Operations high stood at -$20.9 million for Q3 2009, and its period low was -$33.8 million during Q4 2011.
  • In the last 3 years, Lexicon Pharmaceuticals' Income from Continuing Operations had a median value of -$24.6 million in 2010 and averaged -$25.4 million.
  • Within the past 5 years, the most significant YoY rise in Lexicon Pharmaceuticals' Income from Continuing Operations was 5.12% (2011), while the steepest drop was 47.16% (2011).
  • Over the past 3 years, Lexicon Pharmaceuticals' Income from Continuing Operations (Quarterly) stood at -$21.8 million in 2009, then dropped by 5.43% to -$23.0 million in 2010, then slumped by 47.16% to -$33.8 million in 2011.
  • Its Income from Continuing Operations stands at -$33.8 million for Q4 2011, versus -$26.1 million for Q3 2011 and -$26.7 million for Q2 2011.